Page last updated: 2024-11-02

pentoxifylline and Acute Post-Traumatic Stress Disorder

pentoxifylline has been researched along with Acute Post-Traumatic Stress Disorder in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Post-traumatic stress disorder (PTSD) is characterized by a disordered stress response and associated with increased cardiovascular disease risk."5.51Stress-Induced Sensitization of Angiotensin II Hypertension Is Reversed by Blockade of Angiotensin-Converting Enzyme or Tumor Necrosis Factor-α. ( Beltz, TG; Felder, RB; Guo, F; Johnson, AK; Wei, SG; Xue, B; Yu, Y, 2019)
"Post-traumatic stress disorder (PTSD) is characterized by a disordered stress response and associated with increased cardiovascular disease risk."1.51Stress-Induced Sensitization of Angiotensin II Hypertension Is Reversed by Blockade of Angiotensin-Converting Enzyme or Tumor Necrosis Factor-α. ( Beltz, TG; Felder, RB; Guo, F; Johnson, AK; Wei, SG; Xue, B; Yu, Y, 2019)
"Pentoxifylline (PTX) is a potent antioxidant, which has an important role in prevention of cognitive dysfunctions."1.48Pentoxifylline prevents post-traumatic stress disorder induced memory impairment. ( Ahmed, M; Alzoubi, KH; Khabour, OF, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alzoubi, KH1
Khabour, OF1
Ahmed, M1
Xue, B1
Yu, Y1
Wei, SG1
Beltz, TG1
Guo, F1
Felder, RB1
Johnson, AK1

Other Studies

2 other studies available for pentoxifylline and Acute Post-Traumatic Stress Disorder

ArticleYear
Pentoxifylline prevents post-traumatic stress disorder induced memory impairment.
    Brain research bulletin, 2018, Volume: 139

    Topics: Animals; Brain-Derived Neurotrophic Factor; Catalase; Disease Models, Animal; Free Radical Scavenger

2018
Stress-Induced Sensitization of Angiotensin II Hypertension Is Reversed by Blockade of Angiotensin-Converting Enzyme or Tumor Necrosis Factor-α.
    American journal of hypertension, 2019, 08-14, Volume: 32, Issue:9

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Brain; Captopril;

2019